Literature DB >> 26666150

[Diagnosis and management of diabetic nephropathy].

Munehiro Kitada, Daisuke Koya.   

Abstract

Diabetic nephropathy(DN) is the most common cause of chronic kidney disease, leading to end-stage renal disease (ESRD) and cardiovascular disease (CVD). The overall number of patients with DN will continue to increase in parallel with the increasing global pandemic of type 2 diabetes. The detection of albuminuria is most important for diagnosis of early stage of DN, and also estimated glomerular filtration rate (eGFR) should be assessed, because both albuminuria and reduction of GFR are recognized as the independent risk factor for progression of ESRD and initiation of CVD, respectively. Based on landmark clinical trials, both DN and CVD have become preventable by controlling conventional factors, including hyperglycemia targeting HbA1c<7.0%, hypertenstion using renin angiotensin system inhibitors, dyslipidemia using statins or fibrates, and multifactorial treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26666150

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

1.  Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.

Authors:  Shan-Shan Huang; Da-Fa Ding; Sheng Chen; Cheng-Long Dong; Xiao-Long Ye; Yang-Gang Yuan; Ya-Min Feng; Na You; Jia-Rong Xu; Heng Miao; Qiang You; Xiang Lu; Yi-Bing Lu
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.